ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Vanda Receives FDA Approval to Proceed with VSJ-110 for Allergic Conjunctivitis
November 02, 2020Vanda Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application to evaluate Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) activator VSJ-110 (previously known as ... -
Aldeyra Announces Last Patient Dosed in the ALLEVIATE Trial
December 21, 2018Aldeyra Therapeutics announced the last patient has completed dosing in the ALLEVIATE Phase 3 clinical trial of topical ocular reproxalap in patients with allergic conjunctivitis....
Pharma Sources Insight January 2025
